Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
& Ramalingam, T
The body is an integrated system
Starting with 2 mg per week, moving to 4 mg, and then 8 mg weekly for most of the study 5
GLP-1 Agonists - Drug Pipeline Therapeutic Assessment This section of the report covers the analysis of GLP-1 agonists drug candidates based on several segmentations, including: By Phase Late-Stage Products (Phase 3 and Phase 4) Mid-Stage Products (Phase 2) Early-Stage Products (Phase I) Preclinical and Discovery Stage Products By Drug Class Peptides Small Molecules mRNA-based Therapies Antibody-Based Therapies By Route of Administration Oral Parenteral Others GLP-1 Agonists - Pipeline Assessment Segmentation, By Phases The report covers phase I, phase II, phase III, phase IV, and early-phase drugs
US$ 22.23
US$ 22.39
/assets/images/provider/photos/2802570.png)
US$ 24.04
